Moreover, Par3 inactivation was discovered in 8% of squamous cell lung cancers and Par3 immunohistochemical analysis in lung cancers also demonstrated its contribution to cancer development [25]. This evidence concerns the gene PARD3 and squamous cell lung carcinoma.